SMTL ID : 3l17.1

Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 3.00 Å
Oligo State
monomer
Ligands
1 x JZY: 4-methyl-5-(6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine(Non-covalent)
Links
RCSB   PDBe   PDBj   PDBsum   CATH   PLIP
Citation
Sutherlin, D.P. et al., Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer. J.Med.Chem. (2010)
Release Date
2010-02-16
Peptides
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform

Related Entries With Identical Sequence

3csf.1 | 3cst.1 | 3l08.1 | 3l08.2 | 3l16.1 | 3oaw.1 | 3pre.1 | 3prz.1 | 3ps6.1 | 3r7q.1 | 3r7r.1 | 3t8m.1 | 3tl5.1 | 3zvv.1 | 3zw3.1 | 4fa6.1 | 4fad.1 | 4g11.1 | 4gb9.1 | 4hle.1 | 4j6i.1 | 4urk.1 | 5t23.1 | 6fh5.1 | 6gq7.1 | 6t3b.1 | 6t3c.1